Can emergency physicians identify a high mortality subgroup of patients with sepsis: Role of procalcitonin

European Journal of Emergency Medicine

Volumn 15, Issue 1, 2008, Pages 26-33

  Viallon, Alain ^a   Guyomarc'h, Stéphane ^a   Marjollet, Olivier ^a   Berger, Christophe ^a   Carricajo, Anne ^a   Robert, Florianne ^a   Laporte, Sylvie ^a   Lambert, Claude ^a   Page, Yves ^a   Zéni, Fabrice ^a   Bertrand, Jean Claude ^a  

^a SERVICE DE NEUROLOGIE   (France)

Author keywords

Interleukin 6; Procalcitonin; Prognosis; Sepsis; Tumor necrosis factor

Indexed keywords

INTERLEUKIN 6; INTERLEUKIN 8; LACTIC ACID; PROCALCITONIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; BACTEREMIA; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; EMERGENCY PHYSICIAN; EMERGENCY WARD; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SCORING SYSTEM; SEPSIS; SEPTIC SHOCK; TEACHING HOSPITAL;

ADULT; AGED; BIOLOGICAL MARKERS; CALCITONIN; EMERGENCY SERVICE, HOSPITAL; FRANCE; HUMANS; INTERLEUKIN-1; MIDDLE AGED; PROTEIN PRECURSORS; SENSITIVITY AND SPECIFICITY; SEPSIS; SEVERITY OF ILLNESS INDEX; SHOCK, SEPTIC;

EID: 37849052183     PISSN: 09699546     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEJ.0b013e3280ec539b     Document Type: Article

References (64)

1. Dellinger RP. Cardiovascular management of septic shock. Crit Care Med 2003; 31:946-955.
2. Friedman G, Silva E, Vincent JL. Has the mortality of septic shock changed with time? Crit Care Med 1998; 26:2078-2086.
3. Members of the American College of Chest Physicians/Society of Critical Care Medecine Consensus conference (1992). Definitions of sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20:864-874.
4. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International sepsis definitions conference. Crit Care Med 2003; 31:1250-1256.
5. Barriere SL, Lowry SF. An overview of mortality risk prediction in sepsis. Crit Care Med 1995; 23:376-393.
6. Shapiro NI, Wolfe RE, Moore RB, Smith E, Burdick E, Bates DW. Mortality in Emergency Department Sepsis (MEDS) score: a prospectively derived and validated clinical prediction rule. Crit Care Med 2003; 31:670-675.
7. Booth FV, Short M, Shorr AF, Arkins N, Bates B, Qualy RL, Levy H. Application of a population-based severity scoring system to individual patients results in frequent misclassification. Crit Care 2005; 9:R522-R529.
8. Arabi Y, Al Shirawi N, Memish Z, Venkatesh S, Al-Shimemeri A. Assessment of six mortality prediction models in patients admitted with severe sepsis and septic shock to the intensive care unit: a prospective cohort study. Crit Care 2003; 7:R116-R122.
9. Behre G, Schedel I, Nentwig B, Wormann B, Essink M, Levy H. Endotoxin concentration in neutropenic patients with suspected Gram-negative sepsis: correlation with clinical outcome and determination of antiendotoxin care antibodies during therapy with polyclonal immunoglobulin-M-enriched immunoglobulins. Antimicrob Agents Chemother 1992; 36:2139-2146.
10. Wortel CH, von der Möhlen MAM, van Deventer SJH, Sprung CL, Jastremski M, Lubbers MJ. Effectiveness of a human monoclonal antiendotoxin antibody (HA-1A) in Gram-negative sepsis: relationship to endotoxin and cytotokine levels. J Infect Dis 1992; 166:1367-1374.
11. Debets JMH, Kampmeijer R, van der Linden MPMH, et al. Plasma tumor necrosis factor and mortality in critically ill septic patients. Crit Care Med 1989; 17:489-494.
12. Damas P, Reuter A, Gysen P, Demonty J, Lamy M, Franchimont P. Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans. Crit Care Med 1989; 17:975-978.
13. Callandra T, Baumgartner JD, Grau GE, Wu MM, Lambert PH, Schellekens J, et al. Prognostic values of tumor necrosis factor/cachectin, interleukin-1, interferon-α, and interferon-γ in the serum of patients with septic shock. J Infect Dis 1990; 161:982-987.
14. Mira JP, Cariou A, Grall F, et al. Association of TNF2, a TNF-α, with septic shock susceptibility and mortality: a multicenter study. JAMA 1999; 282:561-568.
15. Waage A, Brandtzaeg P, Halstensen A, et al. The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin-6, interleukin-1, and fatal outcome. J Exp Med 1989; 169:333-338.
16. Hack CE, DeGroot ER, Felt-Bersma RJF, et al. Increased plasma levels of interleukin-6 in sepsis. Blood 1989; 74:1704-1710.
17. Calandra T, Gerain J, Heumann D, et al. The Swiss-Dutch J5 Immunoglobulin Study Group. High circulating levels of interleukin-6 in patients with septic shock. Evolution during sepsis, prognostic value, and interplay with other cytokines. Am J Med 1991; 91:23-29.
18. Casey LC, Balk RA, Bone RC. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med 1993; 119:771-778.
19. Zeni F, Freeman B, Natanson C. Anti-inflammatory therapies to treat sepsis and septic shock: a reassessment. Crit Care Med 1997; 25:1095-1100.
20. Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993; 341:515-518.
21. Mylotte JM, Dermott C, Spooner JA. Prospective study of 114 consecutive episodes of Staphylococcus aureus bacteremia. Rev Infect Dis 1987; 9:891-907.
22. Bisbe J, Gatell JM, Puig J, et al. Pseudomonas aeruginosa bacteremia: univariate and multivariate analyses of factors influencing the prognosis in 133 episodes. Rev Infect Dis 1988; 10:629-635.
23. Gallagher PG, Watanakunakorn C. Pseudomonas bacteremia in a community teaching hospital, 1980-84. Rev Infect Dis 1989; 11:846-852.
24. Hilf M, Yu VL, Sharp J, et al. Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients. Am J Med 1989; 87:540-546.
25. Gatell JM, Trilla A, Latorre X, et al. Nosocomial bacteremia in a large Spanish teaching hospital: analysis of factors influencing prognosis. Rev Infect Dis 1988; 10:203-210.
26. Uzun O, Akalin HE, Hayran M, et al. Factors influencing prognosis in bacteremia due to gram-negative organisms: evaluation of 448 episodes in a Turkish university hospital. Clin Infect Dis 1992; 15:866-873.
27. Lemeshow S, Le Gall JR. Modeling the severity of illness of ICU patients. JAMA 1994; 272:1049-1055.
28. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II. A severity of disease classification system. Crit Care Med 1985; 13:818-829.
29. Le Gall JR, Lemeshow S, Saulnier F. A new simplified Acute Physiology Score (SAPS II) based on a European/North American multi center study. JAMA 1993; 270:2957-2962.
30. Lemeshow S, Teres D, Klar J, Avrunin JS, Gehlbach SH, Rapoport J. Mortality probability models (MPM II) based on an international cohord of intensive care unit patients. JAMA 1993; 270:2478-2486.
31. Suistomaa M, Niskanen M, Kari A, Hynynen M, Takala J. Customized prediction models based on APACH II and SAPS II scores in patients with prolonged length of stay in ICU. Intensive Care Med 2002; 28:479-485.
32. De Werra I, Jaccard C, Corradin SB, et al. Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumonia. Crit Care Med 1997; 25:607-613.
33. Gogos CA, Drosou E, Bassaris HP, Skoutelis A. Pro versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options. J Inf Dis 2000;181:176- 180.
34. Pettilä V, Hynninen M, Takkunen O, Kuusela P, Valtonen M. Predictive value of procalcitonin and interleukin 6 in critically ill patients with suspected sepsis. Intensive Care Med 2002; 28:1220-1225.
35. Marecaux G, Pinsky MR, Dupont E, Kahn RJ, Vincent JL. Blood lactate levels are better prognostic indicators than TNF and IL-6 levels in patients with septic shock. Intensive Care Med 1996; 22:404-408.
36. Bernardin G, Pradier C, Tiger F, Deloffre P, Mattei M. Blood pressure and arterial lactate level are early indicators of short-term survival in human septic shock. Intensive Care Med 1996; 22:17-25.
37. Bakker J, Coffernils M, Leon M, et al. Blood lactate levels are superior to oxygen-derived variables in predicting outcome in human septic shock. Chest 1991; 99:956-962.
38. Bakker J, Gris P, Coffernils M, Kahn RJ, Vincent JL. Serial blood lactate levels can predict the development of multiple organ failure following septic shock. Am J Surg 1996; 171:221-226.
39. Gendrel D, Assicot M, Raymond J, et al. Procalcitonin as a marker for the early diagnosis of neonatal infection. J Pediatrics 1996; 128:570-573.
40. Chiesa C, Panero A, Rossi N, Stegagno M, et al. Reliability of procalcitonin concentration for the diagnosis of sepsis in critically ill neonates. Clin Infect Dis 1998; 26:664-672.
41. Gendrel D, Raymond J, Assicot M, et al. Measurement of procalcitonin levels in children with bacterial meningitis. Clin Infect Dis 1997; 24: 1240-1242.
42. Viallon A, Zeni F, Lambert C, Tardy B, et al. High sensitivity and specificity of serum procalcitonin levels in adults with bacterial meningitis. Clin Infect Dis 1999; 28:1313-1316.
43. Christ-Crain M, Jaccard-Stolz D, Bingisser R, et al. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet 2004; 363:600-607.
44. Smith MD, Suputtamongkol Y, Chaowagul W, et al. Elevated serum procalcitonin levels in patients with melioidosis. Clin Infect Dis 1995; 20:641-645.
45. Rau B, Steinbach G, Gansauge F, et al. The potential role of procalcitonin and interleukin 8 in the prediction of infected necrosis in acute pancreatis. Gut 1997; 6:832-838.
46. Meisner M, Tschaikowsky K, Hutzler A, Schick C, Schuttler J. Postoperative plasma concentrations of procalcitonin after different types of surgery. Intensive Care Med 1998; 24:680-684.
47. Bernard L, Ferriere F, Canassus P, et al. Procalcitonin as an early marker of bacterial infection in severely neutropenic febrile adults. Clin Infect Dis 1998; 27:914-915.
48. Viallon A, Zeni F, Lambert C, et al. Serum and ascitic procalcitonin levels in cirrhotic patients with spontaneous bacterial peritonitis: diagnostic value and relationship to proinflammatory cytokines. Intensive Care Med 2000; 26:1082-1088.
49. Al Nawas B, Shah PM. Procalcitonin in acute malaria. Eur J Med Res 1997; 2:206-208.
50. Mimoz O, Benoist JF, Edouard AR, et al. Procalcitonin and C-reactive protein during the early posttraumatic systemic inflammatory response syndrome. Intensive Care Med 1998; 24:185-188.
51. Meisner M, Tschailkowsky K, Hutzler A, et al. Postoperative plasma concentrations of procalcitonin after different types of surgery. Intensive Care Med 1998; 24:680-684.
52. Hensel M, Volk T, Docke WD, et al. Hyperprocalcitonemia in patients with noninfectious SIRS and pulmonary dysfunction associated with cardiopulmonary bypass. Anesthesiology 1998; 89:93-104.
53. Nylen ES, Al Arifi A, Becker KL, et al. Effect of classic heatstroke on serum procalcitonin. Crit Care Med 1997; 25:1362-1365.
54. Schwarz S, Bertram M, Schawb S, et al. Serum procalcitonin levels in bacterial and abacterial meningitis. Crit Care Med 2000; 28:1828-1832.
55. Martinot M, Hansmann Y, De Martino S, et al. Procalcitonin in pyelonephritis and acute community-acquired pneumonia in adults. Presse Med 2001; 30:1091-1096.
56. Urgate H, Silva E, Mercan D, De Mendonça A, Vincent JL. Procalcitonin used as a marker of infection in the intensive care unit. Crit Care Med 1999; 27:498-504.
57. Brunkhorst FM, Wegscheider KZF, Brunkhorst R. Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis, and septic shock. Intensive Care Med 2000; 26:S148-S152.
58. Müller B, Becker KL, Schächinger H, et al. Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med 2000; 28:977-983.
59. Wanner GA, Keel M, Steckholzer U, Beier W, Stocker R, Ertel W. Relationship between procalcitonin plasma levels and severity of injury, sepsis, organ failure, and mortality in injured patients. Crit Care Med 2000; 28:950-957.
60. Harbarth S, Holeckova K, Froidevaux C, et al. Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 2001; 164:396-402.
61. Clayes R, Vinken S, Spapen H, et al. Plasma procalcitonin and C-reactive protein in acute septic shock: clinical and biological correlates. Crit Care Med 2002; 30:757-762.
62. 1-antitrypsin, and lactoferrin compared with clinical variables. Clin Infect Dis 1999; 29:398-407.
63. Langevelde P, Joop K, Loon J, et al. Endotoxin, cytokines, and procalcitonin in febrile patients admitted to the hospital: identification of subjects at high risk of mortality. Clin Infect Dis 2000; 31:1143-1148.
64. Yi Ling C, Tseng CP, Tsay PK, Chang SS, Chiu TF, Chen JC. Procalcitonin as a marker of bacterial infection in the emergency department: an observational study. Crit Care 2004; 8:R12-R20.